Clinical radiology · 2025
Characteristics of the 18F-fluorodeoxyglucose (18F-FDG) and [18F] 9-fluoropropyl-(+)-dihydrotetrabenazine (18F-FP-DTBZ) positron emission tomography (PET) in patients with cognitive impairment in Parkinson's disease.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li S, Lu W, Yan S, Song T, Zhang C, Yang C, Lu J
Аннотация
AIM: Mild cognitive impairment (MCI) is common in Parkinson's disease (PD). This study compared cerebral metabolism and dopaminergic function in PD patients with MCI (PD-MCI) versus those with normal cognition (PD-NC) and healthy controls (HC).
MATERIAL AND METHODS: A total of 78 PD patients (40 PD-MCI, 38 PD-NC) and 28 HC underwent 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) (metabolism) and [18F] 9-fluoropropyl-(+)-dihydrotetrabenazine (18F-FP-DTBZ) PET (dopaminergic vesicular transporter). Group comparisons used t-tests. Correlations between PET measures and cognitive scores (MMSE, MoCA) were assessed.
RESULTS: PD-MCI patients showed significantly reduced FDG uptake in frontal and parietal regions compared to PD-NC (P=0.003, P=0.025). PD-MCI also exhibited lower 18F-FP-DTBZ binding, particularly in bilateral caudate (contralateral P=0.018; ipsilateral P=0.048). In PD patients, FDG uptake in frontal/parietal lobes and 18F-FP-DTBZ uptake in caudate and putamen positively correlated with MMSE and MoCA scores (all P<0.05).
CONCLUSION: Striatal dopamine depletion and hypometabolism in frontal/parietal regions are associated with cognitive deficits in PD-MCI patients.
MATERIAL AND METHODS: A total of 78 PD patients (40 PD-MCI, 38 PD-NC) and 28 HC underwent 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) (metabolism) and [18F] 9-fluoropropyl-(+)-dihydrotetrabenazine (18F-FP-DTBZ) PET (dopaminergic vesicular transporter). Group comparisons used t-tests. Correlations between PET measures and cognitive scores (MMSE, MoCA) were assessed.
RESULTS: PD-MCI patients showed significantly reduced FDG uptake in frontal and parietal regions compared to PD-NC (P=0.003, P=0.025). PD-MCI also exhibited lower 18F-FP-DTBZ binding, particularly in bilateral caudate (contralateral P=0.018; ipsilateral P=0.048). In PD patients, FDG uptake in frontal/parietal lobes and 18F-FP-DTBZ uptake in caudate and putamen positively correlated with MMSE and MoCA scores (all P<0.05).
CONCLUSION: Striatal dopamine depletion and hypometabolism in frontal/parietal regions are associated with cognitive deficits in PD-MCI patients.